The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...

Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker ...

This episode of The Expert Series explores the complex relationship between lupus and fibromyalgia, focusing on definitions, symptoms, overlapping conditions, treatment approaches, mental health ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Being the best, healthiest you by caring for yourself can mean you are better able to provide support and care for your family member with lupus. There are many simple and manageable strategies you ...

Explore the journey of Jaime Miller, physician scientist diagnosed with systemic lupus erythematosus, who is leveraging her medical expertise to empower others through the Lupus Foundation of America.